Trademark Details For SOMAGEN (Serial Number 88150816)

  •  Home
  •  Print
SOMAGEN
1
1
1
0
Serial Number  United States - USPTO 88150816
Registration Number 5904891
Mark
SOMAGEN
Filing Date Oct-11-2018
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Sep-04-2019

First Use in Commerce: Sep-04-2019





Correspondences

NameWilliam W. Stroever COLE SCHOTZ, PC
Address25 MAIN STREET HACKENSACK, NJ 07601 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-15-2018NEW APPLICATION ENTERED   NWAPI
Oct-21-2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Oct-26-2018ASSIGNED TO EXAMINER   DOCKD
Oct-27-2018APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Nov-21-2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Dec-11-2018PUBLISHED FOR OPPOSITION   PUBOA
Dec-11-2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Feb-05-2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Aug-01-2019SOU TEAS EXTENSION RECEIVED   EEXTI
Aug-01-2019SOU EXTENSION 1 FILED   EXT1S
Aug-01-2019SOU EXTENSION 1 GRANTED   EX1GS
Aug-03-2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Sep-05-2019TEAS STATEMENT OF USE RECEIVED   EISUI
Sep-25-2019CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Sep-05-2019USE AMENDMENT FILED   IUAFS
Sep-25-2019STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Oct-02-2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Oct-03-2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Nov-05-2019REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-05-2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Nov-13-2024TEAS SECTION 8 & 15 RECEIVED   E815I
Mar-12-2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Mar-12-2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Mar-12-2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E